NURS 4301 Exam 3 Multimodal
Interventions For Pain Management
Learning Objectives With Correct
Answers
Differentiate cnociceptive cpain c- ccorrect canscaused cby cdamage cto csomatic cor
cvisceral ctissue; cnormal cprocessing cof cstimulus cthat cdamages cnormal ctissue cor chas
cthe cpotential cto cdo cso cif cprolonged; cusually cresponsive cto cnon copioid cand/or
copioid cdrugs; cincludes csuperficial csomatic cpain, cdeep csomatic cpain, cand cvisceral
cpain
Differentiate cneuropathic cpain c- ccorrect canscaused cby cdamage cto cperipheral cnerves
cor cthe cstructures cin cthe cCNS; cabnormal cprocessing cof csensory cinput cby cthe
cperipheral cor ccentral cnervous csystem; cusually cincludes cadjuvant canalgesics;
cincludes ccentral cpain, cperipheral cneuropathies, cdeafferentation cpain, cand
csympathetically cmaintained cpain
Differentiate cacute cpain c- ccorrect canssudden conset; clasts cless cthan cthree cmonths
cor cas clong cas cnormal chealing ctakes cto coccur; cmild cto csevere cpain; cusually chas can
cidentifiable ccause; cpain cdecreases cover ctime cand cgoes caway cwith crecovery;
cmanifestations ccan creflect csympathetic cnervous csystem cactivation
Differentiate cchronic cpain c- ccorrect cansgradual cor csudden conset; clasts clonger cthan
cthree cmonths cor ccontinues cpast cnormal ctime cfor crecovery; cmild cto csevere cpain;
ccause cmay cbe cunknown cor coriginal ccause cmay cdiffer cfrom cmechanisms
cmaintaining cthe cpain; cpain ctypically cdoesn't cgo caway cand cmay chave cperiods cof
, cincreasing cand cdecreasing cseverity; cmanifestations cinclude cflat caffect, cdecreased
cphysical cactivity, cfatigue, cwithdrawal cfrom csocial cinteraction; ctreatment cfocused con
cenhancing cfunction cand cquality cof clife
Explain chow cthe cphysiology cof cnociceptive cpain crelates cto cthe cselection cof
cmultimodal cinterventions cfor cpain crelief c- ccorrect cansthere care cmany cpathways cthat
ccan cbe ccausing cnociceptive cpain, cso cusing ctwo cor cmore cclasses cof canalgesics
ctakes cadvantage cof cvarious cmechanisms cof caction callowing cfor cmore cbroad crelief
cof cpain; cdifferent cmedications cimpact cdifferent clocations cof cthe cpain ctransmission
cpathway c(transduction, ctransmission, cperception, cmodulation) cso cmedications cthat
ctarget cdifferent cpathway clocations ccan cbe cused ctogether cfor cbroader crelief
Describe cthe cmechanism cof caction cfor cacetaminophen c- ccorrect cansinhibit cCOX cin
cCNS conly cto creduce cfever cand cpain c(minimal ceffects con cCOX cin cperipheral csites)
Describe cthe cindication cfor cacetaminophen c- ccorrect cansanalgesic, cantipyretic c(fever
creduction) c(differ cfrom cNSAIDs: clack canti-inflammatory cproperties)
Describe cthe ccontraindications cfor cacetaminophen c- ccorrect cansconcurrent calcohol
cuse cat chigh cdoses cmay ccause cliver cand ckidney cdamage; cwarfarin; cvaccines;
cundernourished; cliver cdisease
Describe cthe cside ceffects cfor cacetaminophen c- ccorrect cansrare cat ctherapeutic
cdoses; cnausea, cvomiting, chepatotoxicity cat chigh cdoses c(alcohol cincreases crisk cof
cliver cdamage)
Describe cthe crecommended cdose cfor cacetaminophen c- ccorrect cans650 cmg cq4-6h
Describe cthe ctoxicity cfor cacetaminophen c- ccorrect cans4,000 cmg/day c(3000 cmg/day
cif cused clong-term); chepatotoxicity cfrom cchronic cdosing cof cmore cthan c3 cg/day,
cacute coverdose, cor cuse cby cpatients cwith csevere cpreexisting cliver cdisease; ctreat
cwith cacetylcysteine cwithin c24 chours cat cthe clatest cfor cprotection
Antidote cfor cacetaminophen coverdose c- ccorrect cansN-acetylcysteine, cactivated
ccharcoal
Describe cthe cnursing cadministration cconsiderations cfor cacetaminophen c- ccorrect
cansmaximum cdaily cdose cof c4000 cmg, cceiling cat c1000 cmg; cacute cliver cfailure cwith
cacute coverdose; cliver ctoxicity cwith cchronic coverdose; cearly ctoxicity csymptoms
cinclude cnausea, cvomiting, cdiarrhea, csweating, cabdominal cdiscomfort cbut conly cshow
cup c48 cto c72 chours cafter chepatic cinjury chas coccurred; cacetylcysteine ccan cminimize
cliver cdamage
Describe cthe cmechanism cof caction cfor cnonsteroidal canti-inflammatory cdrugs
c(NSAIDs) c- ccorrect cansreversible cnonselective cinhibition cof cCOX; cCOX-1 cinhibition
ccauses crenal cfunction cimpairment, cbleeding ctendencies, cGI cirritation, culceration,
Interventions For Pain Management
Learning Objectives With Correct
Answers
Differentiate cnociceptive cpain c- ccorrect canscaused cby cdamage cto csomatic cor
cvisceral ctissue; cnormal cprocessing cof cstimulus cthat cdamages cnormal ctissue cor chas
cthe cpotential cto cdo cso cif cprolonged; cusually cresponsive cto cnon copioid cand/or
copioid cdrugs; cincludes csuperficial csomatic cpain, cdeep csomatic cpain, cand cvisceral
cpain
Differentiate cneuropathic cpain c- ccorrect canscaused cby cdamage cto cperipheral cnerves
cor cthe cstructures cin cthe cCNS; cabnormal cprocessing cof csensory cinput cby cthe
cperipheral cor ccentral cnervous csystem; cusually cincludes cadjuvant canalgesics;
cincludes ccentral cpain, cperipheral cneuropathies, cdeafferentation cpain, cand
csympathetically cmaintained cpain
Differentiate cacute cpain c- ccorrect canssudden conset; clasts cless cthan cthree cmonths
cor cas clong cas cnormal chealing ctakes cto coccur; cmild cto csevere cpain; cusually chas can
cidentifiable ccause; cpain cdecreases cover ctime cand cgoes caway cwith crecovery;
cmanifestations ccan creflect csympathetic cnervous csystem cactivation
Differentiate cchronic cpain c- ccorrect cansgradual cor csudden conset; clasts clonger cthan
cthree cmonths cor ccontinues cpast cnormal ctime cfor crecovery; cmild cto csevere cpain;
ccause cmay cbe cunknown cor coriginal ccause cmay cdiffer cfrom cmechanisms
cmaintaining cthe cpain; cpain ctypically cdoesn't cgo caway cand cmay chave cperiods cof
, cincreasing cand cdecreasing cseverity; cmanifestations cinclude cflat caffect, cdecreased
cphysical cactivity, cfatigue, cwithdrawal cfrom csocial cinteraction; ctreatment cfocused con
cenhancing cfunction cand cquality cof clife
Explain chow cthe cphysiology cof cnociceptive cpain crelates cto cthe cselection cof
cmultimodal cinterventions cfor cpain crelief c- ccorrect cansthere care cmany cpathways cthat
ccan cbe ccausing cnociceptive cpain, cso cusing ctwo cor cmore cclasses cof canalgesics
ctakes cadvantage cof cvarious cmechanisms cof caction callowing cfor cmore cbroad crelief
cof cpain; cdifferent cmedications cimpact cdifferent clocations cof cthe cpain ctransmission
cpathway c(transduction, ctransmission, cperception, cmodulation) cso cmedications cthat
ctarget cdifferent cpathway clocations ccan cbe cused ctogether cfor cbroader crelief
Describe cthe cmechanism cof caction cfor cacetaminophen c- ccorrect cansinhibit cCOX cin
cCNS conly cto creduce cfever cand cpain c(minimal ceffects con cCOX cin cperipheral csites)
Describe cthe cindication cfor cacetaminophen c- ccorrect cansanalgesic, cantipyretic c(fever
creduction) c(differ cfrom cNSAIDs: clack canti-inflammatory cproperties)
Describe cthe ccontraindications cfor cacetaminophen c- ccorrect cansconcurrent calcohol
cuse cat chigh cdoses cmay ccause cliver cand ckidney cdamage; cwarfarin; cvaccines;
cundernourished; cliver cdisease
Describe cthe cside ceffects cfor cacetaminophen c- ccorrect cansrare cat ctherapeutic
cdoses; cnausea, cvomiting, chepatotoxicity cat chigh cdoses c(alcohol cincreases crisk cof
cliver cdamage)
Describe cthe crecommended cdose cfor cacetaminophen c- ccorrect cans650 cmg cq4-6h
Describe cthe ctoxicity cfor cacetaminophen c- ccorrect cans4,000 cmg/day c(3000 cmg/day
cif cused clong-term); chepatotoxicity cfrom cchronic cdosing cof cmore cthan c3 cg/day,
cacute coverdose, cor cuse cby cpatients cwith csevere cpreexisting cliver cdisease; ctreat
cwith cacetylcysteine cwithin c24 chours cat cthe clatest cfor cprotection
Antidote cfor cacetaminophen coverdose c- ccorrect cansN-acetylcysteine, cactivated
ccharcoal
Describe cthe cnursing cadministration cconsiderations cfor cacetaminophen c- ccorrect
cansmaximum cdaily cdose cof c4000 cmg, cceiling cat c1000 cmg; cacute cliver cfailure cwith
cacute coverdose; cliver ctoxicity cwith cchronic coverdose; cearly ctoxicity csymptoms
cinclude cnausea, cvomiting, cdiarrhea, csweating, cabdominal cdiscomfort cbut conly cshow
cup c48 cto c72 chours cafter chepatic cinjury chas coccurred; cacetylcysteine ccan cminimize
cliver cdamage
Describe cthe cmechanism cof caction cfor cnonsteroidal canti-inflammatory cdrugs
c(NSAIDs) c- ccorrect cansreversible cnonselective cinhibition cof cCOX; cCOX-1 cinhibition
ccauses crenal cfunction cimpairment, cbleeding ctendencies, cGI cirritation, culceration,
